11/12 Yahoo! Finance: PFE News

Please add updates@feedmyinbox.com to your address book to make sure you receive these messages in the future. Yahoo! Finance: PFE News - Latest Financial News for PFIZER INC [$$] Drug Makers to Press for Guidance on Web Marketing (at The Wall Street Journal Online) November 11, 2009 at 8:59 pm Advertising Drug Firms Seek Web Guidance Big drug makers, including Eli Lilly and Pfizer, are heading to Washington to press for guidance from the FDA on marketing prescription drugs online. Pharma's Future In Social Media (at Forbes.com) November 11, 2009 at 8:08 pm Review: Reports on Pfizer drug studies misleading (AP) November 11, 2009 at 6:54 pm Analysis of a dozen published studies testing possible new uses for a Pfizer Inc. epilepsy drug found that reporting of the results was often misleading, indicating the medicine worked better than internal company documents showed. Stocks With Reliable Dividends (at The Wall Street Journal Online) November 11, 2009 at 6:14 pm Who Wants to Talk to the FDA About Google and Facebook? (at The Wall Street Journal Online) November 11, 2009 at 5:21 pm Report shows Pfizer's hand in Neurontin studies (at Reuters) November 11, 2009 at 5:15 pm There Will Be Blood (Plasma) (at Motley Fool) November 11, 2009 at 3:46 pm Drug industry presses FDA to allow more online ads (AP) November 11, 2009 at 3:30 pm As federal regulators take their first tentative steps toward policing the wild west of medical information online, pharmaceutical companies are pressing their case to market drugs via Google, Twitter and other Web sites. When Rival Drug Makers Compare Notes On Safety Problems (at The Wall Street Journal Online) November 11, 2009 at 3:07 pm [$$] Keeping Up With the Kahn Brothers (at RealMoney by TheStreet.com) November 11, 2009 at 1:15 pm Pfizer's Chemistry Head Count: Lower than Before the Wyeth Merger (at Seeking Alpha) November 11, 2009 at 11:39 am High Probability ETF Trading: Strategies for Overbought Markets (TradingMarkets.com) November 11, 2009 at 11:22 am The Health Care Select Sector SPDRS ETF, XLV has run into extremely overbought territory- so much so that it's last close had a 2-period RSI of more than 90 for four consecutive days. It's Raining Pink Slips (at Motley Fool) November 11, 2009 at 10:08 am PFIZER INC Financials (EDGAR Online Financials) November 11, 2009 at 9:05 am 3 Stocks With Reliable 3% Dividends (at SmartMoney.com) November 11, 2009 at 5:01 am BMP Sunstone Partners with Pfizer to Distribute Endometriosis Treatment in China (at Seeking Alpha) November 11, 2009 at 4:29 am   This email was sent to gatdemit001@gmail.com.  Create Your Account Don't want to receive this feed any longer? Unsubscribe here.